Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net loss	$ (26,647)	$ (3,038)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation, depletion and amortization	22,249	22,471
Accretion of asset retirement obligation and receivable	5,400	5,840
Amortization of intangible assets and liabilities, net	327	236
Non-cash tax benefits	(167)
Share-based compensation	2,792	2,329
Loss (gain) on sales of assets	324	90
Non-cash interest expense		785
Amortization of deferred financing costs	1,240	1,089
Loss on extinguishment of debt	17,030
Gain on sales of investment securities	(150)	(659)
Loss (gain) on derivative instruments	3,079	(132)
Changes in operating assets and liabilities:
Receivables, net	12,159	(4,795)
Inventories	(2,206)	1,024
Excess of pneumoconiosis benefit obligation over trust assets	762	813
Accounts payable and accrued expenses	(3,683)	3,889
Deferred revenue	(3,639)	534
Accrual for workers' compensation	(105)	(123)
Asset retirement obligation	(4,290)	(2,594)
Accrual for postretirement medical benefits	(961)	(1,709)
Pension and SERP obligations	(701)	190
Other assets and liabilities	1,507	(6,392)
Net cash provided by in operating activities	24,320	19,848
Cash flows from investing activities:
Additions to property, plant and equipment	(11,970)	(9,543)
Change in restricted investments and bond collateral and reclamation deposits	(4,685)	251
Net proceeds from sales of assets	28	380
Proceeds from sale of restricted investments	2,150	1,119
Receivable from customer for property and equipment purchases		(103)
Net cash used in investing activities	(14,477)	(7,896)
Cash flows from financing activities:
Change in book overdrafts	1,803	962
Borrowings from long-term debt, net of debt discount	142,500
Repayments of long-term debt	(64,765)	(11,355)
Borrowings on revolving lines of credit	73,700	75,800
Repayments of revolving lines of credit	(92,100)	(77,200)
Debt issuance and other refinancing costs	(14,819)
Preferred dividends paid	(20,621)	0
Exercise of stock options	422	8
Net cash provided by (used in) financing activities	26,120	(11,785)
Net increase in cash and cash equivalents	35,963	167
Cash and cash equivalents, beginning of period	5,775	10,519
Cash and cash equivalents, end of period	41,738	10,686
Non-cash transactions:
Capital leases	$ 507	$ 866